DRD2, DRD3 and 5HT2A receptor genes polymorphisms in Obsessive-Compulsive Disorder

Molecular Psychiatry

Volumn 1, Issue 6, 1996, Pages 461-465

  Nicolini, H ^a   Cruz, C ^a   Camarena, B ^a   Orozco, B ^a   Kennedy, J L ^c   King, N ^c   Weissbecker, K ^d   De La Fuente, J R ^b   Sidenberg, D ^a  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

^c UNIVERSITY OF TORONTO   (Canada)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Association study; Dopamine; Dopamine D2 receptor gene; Genotype; Obsessive Compulsive Disorder; RFLP

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DRD3 PROTEIN, HUMAN; SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN LEVEL; FEMALE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; MOLECULAR CLONING; OBSESSIVE COMPULSIVE DISORDER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; AGED; BRAIN CHEMISTRY; CLONING, MOLECULAR; FEMALE; GENOTYPE; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, SEROTONIN;

EID: 0030325537     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Nicolini H, Hanna G, Baxter L, Schwartz J, Weissbecker K, Spence MA. Segregation analysis of obsessive-compulsive and associated disorders. Preliminary results. Ursus Med J 1991; 1: 25-28.
2. Rasmussen SA. Genetic studies of obsessive-compulsive disorder. Ann Clin Psychiatry 1993; 5: 241-247.
3. Pauls DL, Alsobrook JP, Goodman W, Rasmussen S, Leckman J. A family study of obsessive-compulsive disorder. Am J Psychiatry 1995; 152: 76-84.
4. Pauls DL, Towbin KE, Leckman JF, Zahner GE, Cohen DJ. Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Arch Gen Psychiatry 1986; 43: 1180-1182.
5. Pauls DL, Leckman JF. The inheritance of Gilles de la Tourette's syndrome and associated behaviours. Evidence for autosomal dominant transmission. New Engl J Med 1986; 315: 993-997.
6. Comings BG, Comings DE. A controlled study of Tourette's syndrome V: depression and mania. Am J Hum Genet 1987; 41: 804-821.
7. Insel TR, Zohar J. Psychopharmacological approaches to obsessive-compulsive disorder. In: Meltzer HY, Coyle JT, Kopin IJ et al (eds). Psychopharmacology: The Third Generation of Progress. Raven Press: New York, 1987, pp 1205-1210.
8. Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: comparison of fluvoxamine and desipramine. Arch Gen Psychiatry 1990; 45: 577-585.
9. Goodman WK, Price LH, Rasmussen SA. Efficacy of fluvoxamine in obsessive-compulsive disorder: a double blind comparison with placebo. Arch Gen Psychiatry 1989; 46: 36-43.
10. McDougle CJ, Goodman WK, Price LH. Dopamine antagonists in tic-related and psychotic: spectrum obsessive compulsive disorder. J Clin Psychiatry 1994; 55: 3 (suppl): 24-31.
11. Stahl SM. Basal ganglia neuropharmacology and obsessive-compulsive disorder: the obsessive-compulsive disorder hypothesis of basal ganglia dysfunction. Psychopharmacol Bull 1988; 24: 370-374.
12. Rapoport JL, Wise SP. Obsessive-compulsive disorder: evidence for basal ganglia dysfunction. Psychopharmacol Bull 1988; 24: 380-384.
13. Satel SL, McDougle CJ. Obsessions and compulsions associated with cocaine abuse [letter]. Am J Psychiatry 1993; 150: 155-156.
14. Jacobsen FM. Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry 1995; 56: 423-429.
15. Caraveo J, Gonzalez C, Ramos L. Concurrent validity of the DIS experience with psychiatric patients in Mexico City. Hispan J Behav Sci 1991; 13: 63-67.
16. Nicolini H, Kuthy I, Hernandez E, Cortes J, Gonzalez H, Bauer J. Translation and reliability of the Spanish version of the Yale-Brown obsessive-compulsive scale. Anales del IMP 1991; 3: 25-28.
17. Nicolini H, Sanchez de Carmona M, Weissbecker K. Family study of obsessive-compulsive disorder on a Mexican population. Arch Med Res 1993; 24: 193-198.
18. Kawasaki ES. Sample preparations from blood, cells, and other fluids. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds). PCR Protocols: a Guide to Methods and Applications. Academic Press: San Diego, 1990, pp 146-152.
19. Cruz G, Camarena M, Paez F, Eroza V, de la Fuente JR, Kershonobich D, Nicolini H. Dopamine D2 receptor gone TaqI-A1 polymorphism and alcoholism in a Mexican population. Arch Med Res 1995; 26: 421-426.
20. Grandy DK, Zhang Y, Civelli O. PCR detection of the TaqI A RFLP at the DRD2 locus. Hum Mol Genet 1993; 2: 2197.
21. Lannfelt L, Sokoloff P, Martres MP, Pilon C, Giros B, Jönsson E, Sedvall G, Schwartz JC. Amino acid substitution in the dopamine D3 receptor as useful polymorphism for investigating psychiatric disorders. Psychiatric Genet 1992; 2: 249-252.
22. Warren JT, Peacock ML, Rodriguez LC, Fink JK. MspI polymorphism in the human serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. Hum Mol Genet 1993; 2: 338.
23. Crocq MA, Mant R, Asherson P, Williams J, Hode Y, Mayerova A, Collier D, Lannfelt L, Sokoloff P, Schwartz J-C, Gill M, Macher M-P, McGuffin P, Owen MJ. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 1992; 29: 858-860.
24. Comings DE, Muhleman D, Dietz G, Dino M, LeGro R, Cade R. Association between Tourette's syndrome and homozygosity at the dopamine D3 receptor gene. Lancet 1993; 341: 906.
25. Inayama Y, Yoneda H, Ishida T, Nonomura Y, Kono Y, Koh J, Kuroda K, Higashi H, Asaba H, Sakai T. An association between schizophrenia and a serotonin receptor marker (5HTR2). Neuropsychopharmacology 1994; 10: 36S.
26. Arranz M, Collier D, Sodhi M, Ball D, Roberts G, Price J, Kerwin R. Association between clozapine response and allelic variation in 5HT2A receptor gene. Lancet 1995; 346: 281-282.
27. Blum K, Cull JG, Braverman ER, Comings DE. Reward deficiency syndrome. Amer Scient 1996; 84: 1321-1345.
28. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. Allelic association of the D2 receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 1993; 48: 648-654.
29. Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocksis P, Baumgarten R, Kovacs BW, Levy DL, Smith M, Borison RL, Evans DD, Klein DN, Macmurray J, Tosk JM, Sverd J, Gysin R, Flanagan SD. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 1991; 266: 1793-1800.
30. Devor EJ. The D2 dopamine receptor and Tourette's syndrome. JAMA 1992; 267: 651.
31. Nothen MM, Hebebrand J, Knapp M, Hebebrand K, Camps A, von Gontard A, Wettke-Schäfer R, Lisch S, Cichon S, Poustka F, Schmidt M, Lehmkuhl G, Remschmidt H, Propping P. Association analysis of the dopamine D2 receptor in Tourette's syndrome using the haplotype relative risk method. Am J Med Genet 1994; 5: 249-252.
32. Comings DE. The D2 dopamine receptor and Tourette's syndrome. JAMA 1992; 267: 652.
33. Gelernter J, Leckman J, Pauls DL, Kidd KK, Kurlan R. Dopamine D2 receptor and Tourette's syndrome. Arch Neurol 1995; 52: 442-443.
34. Pakstis AJ, Heuntink P, Pauls DL, Kurlan R, van de Wetering M, Leckman JL, Sankuyl LA, Kidd JR, Breedveld GJ, Castiglione CM, Weber J, Sparkes RS, Cohen DJ, Kidd KK, Oostra BA. Progress in the search for genetic linkage with Tourette's syndrome: an exclusion map covering more than 50% of the autosomal genome. Am J Hum Genet 1991; 48: 281-294.
35. Devor EJ. Linkage studies in 26 St Louis families. Present status and pursuit of adjunct strategy. Adv Neurol 1992; 58: 181-187.
36. Gelernter J, Pauls DL, Leckman J, Kidd KK, Kurlan R. D2 dopamine receptor alleles do not influence severity of Tourette's syndrome: results from four large kindred. Arch Neurol 1994; 5: 397-400.
37. Novelli E, Nobile M, Diaferia G, Sciuto G, Catalano M. A molecular investigation suggests no relationship between obsessive-compulsive disorder and the dopamine D2 receptor. Neuropsychobiology 1994; 29: 61-63.
38. Barr CL, Kidd KK. Population frequencies of the A1 allele at the dopamine D2 receptor locus. Biol Psychiatry 1993; 34: 204-209.
39. Falk CT, Rubinstein P. Haplotype relative risk: an easy reliable way to construct a control sample for risk calculations. Ann Hum Genet 1987; 51: 227-233.
40. Terwilliger JD, Ott J. A haplotype-based 'Haplotype relative risk' approach to detecting allelic associations. Hum Hered 1992; 42: 337-346.
41. Knapp M, Seuchter SA, Baur MP. The haplotype-relative-risk (HRR) method for analysis of association in nuclear families. Am J Hum Genet 1993; 52: 1085-1093.
42. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.